Tripokin: A multi-specific immunocytokine for cancer immunotherapy.

Autor: Prodi E; Philochem AG, Otelfingen, Switzerland.; CiBIO (Department of Cellular, Computational and Integrative Biology), University of Trento, Trento, Italy., Corbellari R; Philochem AG, Otelfingen, Switzerland.; CiBIO (Department of Cellular, Computational and Integrative Biology), University of Trento, Trento, Italy., Ghezzi L; Philogen Spa, Siena, Italy., Ciambellotti S; Philogen Spa, Siena, Italy., Catastini JE; Philogen Spa, Siena, Italy., Rappuoli M; Philogen Spa, Siena, Italy., Rotta G; Philochem AG, Otelfingen, Switzerland., Sakic I; Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Weiss T; Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Weller M; Department of Neurology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Pellegrino C; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Neri D; Philogen Spa, Siena, Italy.; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland., De Luca R; Philochem AG, Otelfingen, Switzerland.

Publikováno v: International journal of cancer [Int J Cancer] 2025 Jan 01; Vol. 156 (1), pp. 216-228. Date of Electronic Publication: 2024 Aug 23.